Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donna Graves

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Journal of Clinical Apheresis|February 10, 2015
Intravenous methylprednisolone versus therapeutic plasma exchange for treatment of anti-N-methyl-D-aspartate receptor antibody encephalitis: A retrospective reviewAllen D DeSena, Daniel K Noland, Karen Matevosyan, et al.
Therapeutic Advances in Neurological Disorders|July 12, 2012
Current and emerging therapies in multiple sclerosis: a systematic reviewWanda Castro-Borrero, Donna Graves, Teresa C Frohman, et al.
JAMA Neurology|September 30, 2014
The effect of glatiramer acetate therapy on functional properties of B cells from patients with relapsing-remitting multiple sclerosisSara J Ireland, Alyssa A Guzman, Dina E O'Brien, et al.
Therapeutic Advances in Neurological Disorders|June 23, 2011
Symptomatic therapy in multiple sclerosisTeresa C Frohman, Wanda Castro, Anjali Shah, et al.
ASN Neuro|October 23, 2015
A Distinct Class of Antibodies May Be an Indicator of Gray Matter Autoimmunity in Early and Established Relapsing Remitting Multiple Sclerosis PatientsAnn J Ligocki, Jacqueline R Rivas, William H Rounds, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Journal of Clinical Apheresis|February 10, 2015
Intravenous methylprednisolone versus therapeutic plasma exchange for treatment of anti-N-methyl-D-aspartate receptor antibody encephalitis: A retrospective reviewAllen D DeSena, Daniel K Noland, Karen Matevosyan, et al.
Therapeutic Advances in Neurological Disorders|July 12, 2012
Current and emerging therapies in multiple sclerosis: a systematic reviewWanda Castro-Borrero, Donna Graves, Teresa C Frohman, et al.
JAMA Neurology|September 30, 2014
The effect of glatiramer acetate therapy on functional properties of B cells from patients with relapsing-remitting multiple sclerosisSara J Ireland, Alyssa A Guzman, Dina E O'Brien, et al.
Therapeutic Advances in Neurological Disorders|June 23, 2011
Symptomatic therapy in multiple sclerosisTeresa C Frohman, Wanda Castro, Anjali Shah, et al.
ASN Neuro|October 23, 2015
A Distinct Class of Antibodies May Be an Indicator of Gray Matter Autoimmunity in Early and Established Relapsing Remitting Multiple Sclerosis PatientsAnn J Ligocki, Jacqueline R Rivas, William H Rounds, et al.
Pageof 2